Evidence map›Paper›PMID 39487120›Full record

ArticleNature communications2024

Distinct Escherichia coli transcriptional profiles in the guts of recurrent UTI sufferers revealed by pangenome hybrid selection.

Mark G Young, Timothy J Straub, Colin J Worby, Hayden C Metsky, Andreas Gnirke, Ryan A Bronson, Lucas R van Dijk, Christopher A Desjardins, Christian Matranga, James Qu and 8 more

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. More than an infection: the ecological puzzle of recurrent urinary tract infections.Frontiers in cellular and infection microbiology · 2026
    Review
  7. Review
  8. Systematic evaluation of metatranscriptomic differential gene expressionbioRxiv : the preprint server for biology · 2025
    Article
  9. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors.

Mark G Young *Infectious Disease & Microbiome Program, Broad Institute, Cambridge, MA, 02142, USA.ORCID 0009-0001-4111-9329
Timothy J Straub *Infectious Disease & Microbiome Program, Broad Institute, Cambridge, MA, 02142, USA.ORCID 0000-0001-5009-0778
Colin J WorbyInfectious Disease & Microbiome Program, Broad Institute, Cambridge, MA, 02142, USA.ORCID 0000-0002-9132-7249
Hayden C MetskyInfectious Disease & Microbiome Program, Broad Institute, Cambridge, MA, 02142, USA.ORCID 0000-0002-8871-2349
Andreas GnirkeInfectious Disease & Microbiome Program, Broad Institute, Cambridge, MA, 02142, USA.ORCID 0000-0001-5324-6387
Ryan A BronsonInfectious Disease & Microbiome Program, Broad Institute, Cambridge, MA, 02142, USA.
Lucas R van DijkInfectious Disease & Microbiome Program, Broad Institute, Cambridge, MA, 02142, USA.ORCID 0000-0002-7565-5859
Christopher A DesjardinsInfectious Disease & Microbiome Program, Broad Institute, Cambridge, MA, 02142, USA.
Christian MatrangaInfectious Disease & Microbiome Program, Broad Institute, Cambridge, MA, 02142, USA.
James QuInfectious Disease & Microbiome Program, Broad Institute, Cambridge, MA, 02142, USA.
Jesús Bazan VillicanaDepartment of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO, USA.ORCID 0000-0001-8724-3213
Philippe AzimzadehDepartment of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO, USA.
Andrew KauDepartment of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO, USA.ORCID 0000-0002-9386-3766
Karen W DodsonDepartment of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO, USA.
Henry L SchreiberDepartment of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO, USA.ORCID 0000-0002-4501-9886
Abigail L MansonInfectious Disease & Microbiome Program, Broad Institute, Cambridge, MA, 02142, USA.ORCID 0000-0002-3800-0714
Scott J HultgrenDepartment of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO, USA.ORCID 0000-0001-8785-564X
Ashlee M EarlInfectious Disease & Microbiome Program, Broad Institute, Cambridge, MA, 02142, USA. aearl@broadinstitute.org.ORCID 0000-0001-7857-9145

Funding

Viral Genomics: evolution, spread, and host interactionsU19AI110818 · NIAID · BROAD INSTITUTE, INC. · PI BIRREN, BRUCE W., NEAFSEY, DANIEL E · 2014 to 2024
$66.5M
Epidemiologic and molecular basis of the gut-urinary tract axis in urinary tract infectionR01DK121822 · NIDDK · WASHINGTON UNIVERSITY · PI Ashlee Miriam Earl, SCOTT J. HULTGREN · 2020 to 2026
$4.9M
Harnessing Antibody Responses to Prevent and Treat Urinary Tract InfectionsR01AI165915 · NIAID · WASHINGTON UNIVERSITY · PI Andrew Leon Kau · 2022 to 2026
$3.1M
Role of estrous cycle and contraceptives in anogenital papillomavirus infectionR21AI121822 · NIAID · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI CHRISTENSEN, NEIL D, HU, JIAFEN · 2016 to 2017
$425k
NIAID NIH HHS R01 AI165915NIAID NIH HHS U19 AI110818NIDDK NIH HHS R01 DK121822U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID) R01AI165915U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID) R01DK121822U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID) U19AI110818
6 · The paper itself

Abstract

Low-abundance members of microbial communities are difficult to study in their native habitats, including Escherichia coli, a minor but common inhabitant of the gastrointestinal tract, and key opportunistic pathogen of the urinary tract. While multi-omic analyses have detailed interactions between uropathogenic Escherichia coli (UPEC) and the bladder mediating urinary tract infection (UTI), little is known about UPEC in its pre-infection reservoir, the gastrointestinal tract, partly due to its low relative abundance (<1%). To sensitively explore the genomes and transcriptomes of diverse gut E. coli, we develop E. coli PanSelect, which uses probes designed to specifically capture E. coli's broad pangenome. We demonstrate its ability to enrich diverse E. coli by orders of magnitude, in a mock community and in human stool from a study investigating recurrent UTI (rUTI). Comparisons of transcriptomes between gut E. coli of women with and without history of rUTI suggest rUTI gut E. coli are responding to increased oxygen and nitrate, suggestive of mucosal inflammation, which may have implications for recurrent disease. E. coli PanSelect is well suited for investigations of in vivo E. coli biology in other low-abundance environments, and the framework described here has broad applicability to other diverse, low-abundance organisms.

Indexed as

Escherichia coliEscherichia coli InfectionsGenome, BacterialTranscriptomeUrinary Tract InfectionsUropathogenic Escherichia coliAdultFecesFemaleGastrointestinal MicrobiomeGastrointestinal TractHumansRecurrence

Identifiers

PMID39487120
PMCPMC11530686

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.